Blink-powered glasses could keep an eye on health
October 17, 2026
The ultra-low-power design could pave the way for smart glasses that continuously monitor health without constant charging.
The ultra-low-power design could pave the way for smart glasses that continuously monitor health without constant charging.
When Dr. Kourosh Parham conceived a first-of-its-kind blood test for tinnitus, he knew further research was needed to confirm a link between a unique ear protein and the common hearing disorder. To validate his theory, the professor of surgery at UConn Health (UCH), Division of Otolaryngology-Head & Neck Surgery, teamed up with fellow UCH physician-scientists to conduct two clinical trials.
Shenzhen, China, Oct. 10, 2026 /PRNewswire/ — Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for non-invasive blood oxygen (SpO2) measurement (Clearance No. K260490).
Newly cleared CraniUS® Plate configuration, designated NeuroPASS 2, adds an opening designed to accommodate an implantable intracranial pressure sensor; issued patent protects the integrated drug delivery architecture at the heart of NeuroPASS 3.
TOLEDO, Ohio, Oct. 7, 2026 /PRNewswire/ — True Indicating, LLC today announced they received FDA clearance of InstaTRU™, an instant biological indicator for steam sterilization cycles that provides results in just 20 seconds. Using spore-based technology, InstaTRU™ confirms the efficacy of a steam sterilization cycle without requiring an incubator or reader.
Inflammatory conditions in the brain, including traumatic brain injury and degenerative diseases like Alzheimer’s, could be targeted with an existing drug thanks to new research that shows it can work in brain cells.
A large study shows that machine-learning clocks based on speech can estimate chronological age and may also offer a window into brain aging, biological aging, cognitive health, cumulative burden and dementia.
AKRON, Ohio, Sept. 22, 2026 /PRNewswire/ — Resivant Medical announced today that the U.S. Patent and Trademark Office has issued Patent No. 12,678,148, covering the novel single-lever, single-handed applicator design at the core of the Cutiva™ PLUS Skin Closure System. The patent protects the mechanism that allows clinicians to start, control, and stop the flow of adhesive using a single lever, without repositioning the hand or device.
In mice, adding the therapy to semaglutide led to greater loss of weight and fat while preserving more lean mass
AI in eye care is set to take a new leap with an AI-native rather than assisted approach. Researchers have developed a new tool that moves beyond the conventional model of deploying AI as isolated, standalone tools for individual tasks by bringing together a network of specialized AI software agents that can operate across every stage of a patient’s care pathway.